FARXIGA
AstraZeneca AB
Mark For: FARXIGA® trademark registration is intended to cover the category of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88639033 |
| Registration Number | 6042465 |
| Mark Literal Elements | FARXIGA |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-01-09 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | Yes |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Wm. Charles Saunders |
| Law Office Assigned | L40 |
| Employee Name | FATHY, DOMINIC |
Timeline
| 2017-02-00 | Date of First Use |
| 2017-02-01 | Date of First Use |
| 2017-02-01 | Date of Use In Commerce |
| 2019-10-02 | Application Filed |
| 2020-01-07 | Location: TMEG LAW OFFICE 104 |
| 2020-01-07 | Status: Live/Pending |
| 2020-01-07 | Transaction Date |
| 2020-01-09 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-01-09 | Status: Review prior to publication completed. |
| 2020-02-11 | Published |
| 2020-04-28 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  AstraZeneca AB |
| Address | Astraallén Södertälje SWEDEN SE-15185 |
| Legal Entity Type | Aktiebolag (ab) |
| Legal Entity State | SWEDEN |
Documents
 Drawing | JPEG | 2019-10-02 |
| Specimen | JPEG | 2019-10-02 |
 TEAS RF New Application | MULTI | 2019-10-02 |
| Notation to File | XML | 2020-01-08 |
| XSearch Search Summary | XML | 2020-01-08 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2020-01-09 |
| Notice of Publication | XML | 2020-01-22 |
| Notification Of Notice of Publication | XML | 2020-01-22 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders. FIRST USE: 20170200. FIRST USE IN COMMERCE: 20170200
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders |
| GS0051 | Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-01-22 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-08 | |
| ASSIGNED TO EXAMINER | 2020-01-07 | 81854 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-10-05 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-10-05 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FARXIGA 88639033 not registered Live/Pending |
AstraZeneca AB 2019-10-02 |
 FARXIGA 86049285 4638205 Live/Registered |
Bristol-Myers Squibb Company 2013-08-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 